Estrella Immunopharma Inc (ESLA)

08:30 AM

Estrella Immunopharma secures $3.35M in financing to advance clinical triall; shares up - MSN

08:30 AM

Dec 07, 2025

Estrella Immunopharma shares gain as CD19 cancer therapy progresses into phase II - MSN

Dec 07, 2025

Dec 06, 2025

Estrella Immunopharma (ESLA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Dec 05, 2025

Estrella’s EB103 advances to Phase II after positive safety data By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 04, 2025

Estrella Immunopharma Advances STARLIGHT-1 Trial to Phase II - TradingView

Dec 04, 2025

Dec 04, 2025

Estrella Immunopharma stock rises as cancer therapy advances to Phase II - Investing.com Canada

Dec 04, 2025

Dec 04, 2025

Estrella’s EB103 advances to Phase II after positive safety data - Investing.com

Dec 04, 2025

Dec 04, 2025

Estrella advances Starlight-1 trial into phase II following positive DSMB recommendation - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Estrella (NASDAQ: ESLA) passes DSMB; EB103 high-dose cohort reports 100% CR - Stock Titan

Dec 04, 2025

Dec 04, 2025

Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation - Business Wire

Dec 04, 2025

Dec 04, 2025

Is Estrella Immunopharma Inc. stock a defensive play in 2025Portfolio Gains Summary & Daily Growth Stock Investment Tips - Newser

Dec 04, 2025

Nov 30, 2025

Here's Why We're Not Too Worried About Estrella Immunopharma's (NASDAQ:ESLA) Cash Burn Situation - Sahm

Nov 30, 2025

Nov 22, 2025

Estrella Immunopharma (NASDAQ:ESLA) Raised to “Hold” at Wall Street Zen - Defense World

Nov 22, 2025

Nov 22, 2025

Estrella Immunopharma (NASDAQ:ESLA) Raised to "Hold" at Wall Street Zen - MarketBeat

Nov 22, 2025

Nov 20, 2025

How Estrella Immunopharma Inc. stock benefits from global expansionInsider Buying & Free Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Published on: 2025-11-19 23:49:15 - newser.com

Nov 20, 2025

Nov 19, 2025

Is Estrella Immunopharma Inc. stock oversold or undervaluedStock Surge & Free High Accuracy Swing Entry Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What data driven models say about Estrella Immunopharma Inc.’s futureJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is now a turning point for Estrella Immunopharma Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - newser.com

Nov 19, 2025

Nov 16, 2025

Is Estrella Immunopharma Inc. building a consolidation baseMarket Trend Review & Precise Buy Zone Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Will Estrella Immunopharma Inc. stock gain from government policies2025 Key Lessons & AI Driven Stock Price Forecasts - newser.com

Nov 16, 2025

Nov 15, 2025

Published on: 2025-11-15 19:23:21 - newser.com

Nov 15, 2025

Nov 15, 2025

Is Estrella Immunopharma Inc. reversing from oversold territoryEntry Point & Step-by-Step Swing Trade Plans - newser.com

Nov 15, 2025

Nov 15, 2025

How to integrate Estrella Immunopharma Inc. into portfolio analysis tools - newser.com

Nov 15, 2025

Nov 14, 2025

Published on: 2025-11-14 10:46:07 - newser.com

Nov 14, 2025

Nov 14, 2025

10-Q: Quarterly report - 富途牛牛

Nov 14, 2025

Nov 13, 2025

Get in on Estrella Immunopharma Inc’s (ESLA) buy-in window today! - Setenews

Nov 13, 2025